Philips Recognized for the Thirteenth Consecutive Year Among Global Innovators
Royal Philips has been included in the Clarivate Top 100 Global Innovator 2026 ranking, according to the press release published this Tuesday. The Dutch medical technology company ranks at the top among firms in the sector.
The ranking established by Clarivate is based on a comparative analysis of global invention data and assesses the strength of each patented idea, the company indicates. This distinction comes as Philips invests more than 1.7 billion euros annually in research and development, which is about 9% of its revenue. According to the company, this level of investment is among the highest in the sector. Roy Jakobs, CEO of Royal Philips, stated that this recognition reflects the company's commitment to patient-centered and evolving innovation.
Advancing Medical Technology
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
According to the press release, Philips is developing solutions that combine artificial intelligence, advanced imaging, and connected platforms. These technologies aim to support more accurate diagnostics, simplify clinical workflows, and enable patients to proactively manage their health. The company operates in both professional health and consumer health domains, the statement specifies.
Corporate Footprint and Financial Performance
Royal Philips, headquartered in the Netherlands, employs about 67,000 people and operates in over 100 countries, according to the provided information. The group generated a revenue of 18 billion euros in 2024. The company is listed on the Amsterdam Stock Exchange under the ticker PHIA and on the New York Stock Exchange under the symbol PHG. Its operations encompass diagnostic imaging, ultrasound, image-guided therapy, hospital monitoring and informatics, as well as personal health.
SectorSanté · Technologie · Dispositifs médicaux›Équipements Médicaux
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Contexte
Period
Period: 1T2026
Key reported figures
Revenue: 3.9MD€
Free cash flow: 28M€
Guidance from the release
Nous avons délivré un bon départ en 2026.
Bonne performance au T1, croissance des ventes et des marges.
Risks mentioned
Impact des tarifs et inflation des coûts sur les marges.
Environnement macroéconomique incertain impactant les performances.
Opportunities identified
Croissance des ventes comparables de 4% dans tous les segments.
Augmentation du carnet de commandes grâce à des innovations.
Les informations présentées dans cet article sont fournies à titre purement indicatif et ne constituent en aucun cas une recommandation d'investissement, une incitation à acheter ou vendre un actif financier, ni un conseil en placement. Le lecteur est invité à réaliser ses propres recherches avant toute décision.
Les investissements en bourse comportent des risques, notamment de perte en capital. La performance passée d'un actif ou d'un marché ne présage en rien de ses performances futures. Toute décision d'investissement doit être prise en tenant compte de votre situation financière personnelle, de vos objectifs et de votre tolérance au risque.
